Covalon Technologies Ltd. (“the Company”) is incorporated under the laws of Ontario and is engaged in the business of developing, licensing, and selling medical technologies. The Company has received regulatory approval on numerous products and is currently generating revenue. The Company has adopted a business model that contracts the manufacturing and distribution of its commercialized products through partners. The Company generates its revenues through development contracts, licensing agreements, and distribution contracts and sales. The Company is listed on the TSX Venture Exchange, having the symbol COV.
Stock Quote
TSXV :  COV.V (Common Stock)
0.00 (0.00%)
Stock chart for: COV.V.  Currently trading at Can$5.60 with a 52 week high of Can$5.75 and a 52 week low of Can$1.62.
Data as of January 17, 2018 3:52 p.m. ET
Minimum 15 minute delay
Refresh quote
Recent NewsMore »
Upcoming EventsMore »
February 06, 2018
MD&M West 2018
February 12, 2018
Release of 2018 First Quarter Financial Results
February 13, 2018
Conference Call to Discuss 2018 First Quarter Results
Data provided by Nasdaq. Minimum 15 minutes delayed.